@article{TLCR47830,
author = {Youli Luo and Yunpeng Yang and Peijian Peng and Jianhua Zhan and Zhihui Wang and Zhiquan Zhu and Zhonghan Zhang and Lin Liu and Wenfeng Fang and Li Zhang},
title = {Cholesterol synthesis disruption combined with a molecule-targeted drug is a promising metabolic therapy for EGFR mutant non-small cell lung cancer},
journal = {Translational Lung Cancer Research},
volume = {10},
number = {1},
year = {2021},
keywords = {},
abstract = {},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/47830}
}